annual SGA:
$2.95B+$323.10M(+12.28%)Summary
- As of today (June 2, 2025), REGN annual SGA is $2.95 billion, with the most recent change of +$323.10 million (+12.28%) on December 31, 2024.
- During the last 3 years, REGN annual SGA has risen by +$1.13 billion (+61.89%).
- REGN annual SGA is now at all-time high.
Performance
REGN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$633.00M-$159.20M(-20.10%)Summary
- As of today (June 2, 2025), REGN quarterly SGA is $633.00 million, with the most recent change of -$159.20 million (-20.10%) on March 31, 2025.
- Over the past year, REGN quarterly SGA has dropped by -$56.00 million (-8.13%).
- REGN quarterly SGA is now -20.10% below its all-time high of $792.20 million, reached on December 31, 2024.
Performance
REGN quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$124.23B+$4.40B(+3.67%)Summary
- As of today (June 2, 2025), REGN TTM SGA is $124.23 billion, with the most recent change of +$4.40 billion (+3.67%) on March 31, 2025.
- Over the past year, REGN TTM SGA has increased by +$121.51 billion (+4468.52%).
- REGN TTM SGA is now at all-time high.
Performance
REGN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
REGN Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.3% | -8.1% | +4468.5% |
| 3 y3 years | +61.9% | +40.7% | +6545.6% |
| 5 y5 years | +120.2% | +72.3% | +8660.1% |
REGN Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.9% | -20.1% | +40.7% | at high | +75.6% |
| 5 y | 5-year | at high | +120.2% | -20.1% | +108.6% | at high | +345.4% |
| alltime | all time | at high | >+9999.0% | -20.1% | >+9999.0% | at high | +2627.1% |
REGN Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $633.00M(-20.1%) | $2.90B(-1.9%) |
| Dec 2024 | $2.95B(+12.3%) | $792.20M(+10.9%) | $2.95B(+1.9%) |
| Sep 2024 | - | $714.40M(-5.9%) | $2.90B(+2.6%) |
| Jun 2024 | - | $758.80M(+10.1%) | $2.83B(+3.9%) |
| Mar 2024 | - | $689.00M(-6.6%) | $2.72B(+3.3%) |
| Dec 2023 | $2.63B(+24.4%) | $737.70M(+15.2%) | $2.63B(+3.0%) |
| Sep 2023 | - | $640.50M(-1.8%) | $2.55B(+4.6%) |
| Jun 2023 | - | $652.00M(+8.5%) | $2.44B(+7.8%) |
| Mar 2023 | - | $601.10M(-9.0%) | $2.27B(+7.1%) |
| Dec 2022 | $2.12B(+15.9%) | $660.50M(+24.8%) | $2.12B(+5.0%) |
| Sep 2022 | - | $529.10M(+11.1%) | $2.02B(+4.4%) |
| Jun 2022 | - | $476.30M(+5.8%) | $1.93B(+3.3%) |
| Mar 2022 | - | $450.00M(-19.6%) | $1.87B(+2.4%) |
| Dec 2021 | $1.82B(+35.6%) | $559.60M(+25.8%) | $1.82B(+16.3%) |
| Sep 2021 | - | $445.00M(+7.3%) | $1.57B(+8.1%) |
| Jun 2021 | - | $414.70M(+2.2%) | $1.45B(+4.8%) |
| Mar 2021 | - | $405.60M(+33.6%) | $1.38B(+2.8%) |
| Dec 2020 | $1.35B(+0.3%) | $303.50M(-7.2%) | $1.35B(-9.9%) |
| Sep 2020 | - | $326.90M(-6.1%) | $1.49B(+1.5%) |
| Jun 2020 | - | $348.30M(-5.2%) | $1.47B(+3.8%) |
| Mar 2020 | - | $367.30M(-18.7%) | $1.42B(+5.7%) |
| Dec 2019 | $1.34B(+19.0%) | $451.80M(+48.4%) | $1.34B(+40.9%) |
| Sep 2019 | - | $304.40M(+3.3%) | $952.40M(-6.4%) |
| Jun 2019 | - | $294.60M(+1.2%) | $1.02B(-6.5%) |
| Mar 2019 | - | $291.10M(+367.3%) | $1.09B(-3.5%) |
| Dec 2018 | $1.13B(-14.6%) | $62.30M(-83.1%) | $1.13B(-23.6%) |
| Sep 2018 | - | $369.20M(+1.2%) | $1.47B(+4.4%) |
| Jun 2018 | - | $364.80M(+10.3%) | $1.41B(+4.3%) |
| Mar 2018 | - | $330.80M(-19.3%) | $1.35B(+2.6%) |
| Dec 2017 | $1.32B(+12.1%) | $409.88M(+33.6%) | $1.32B(+6.8%) |
| Sep 2017 | - | $306.77M(-0.0%) | $1.24B(+3.1%) |
| Jun 2017 | - | $306.91M(+3.4%) | $1.20B(+1.3%) |
| Mar 2017 | - | $296.85M(-8.9%) | $1.18B(+0.6%) |
| Dec 2016 | $1.18B(+40.4%) | $325.94M(+20.7%) | $1.18B(+2.7%) |
| Sep 2016 | - | $270.05M(-7.5%) | $1.15B(+5.5%) |
| Jun 2016 | - | $292.04M(+0.8%) | $1.09B(+12.1%) |
| Mar 2016 | - | $289.68M(-1.8%) | $969.21M(+15.6%) |
| Dec 2015 | $838.53M(+61.5%) | $294.95M(+40.5%) | $838.53M(+16.6%) |
| Sep 2015 | - | $209.99M(+20.3%) | $718.88M(+10.1%) |
| Jun 2015 | - | $174.59M(+9.8%) | $652.89M(+13.5%) |
| Mar 2015 | - | $158.99M(-9.3%) | $575.03M(+10.7%) |
| Dec 2014 | $519.27M(+49.9%) | $175.31M(+21.7%) | $519.27M(+17.2%) |
| Sep 2014 | - | $144.00M(+48.9%) | $443.02M(+11.7%) |
| Jun 2014 | - | $96.73M(-6.3%) | $396.63M(+6.5%) |
| Mar 2014 | - | $103.23M(+4.2%) | $372.36M(+7.5%) |
| Dec 2013 | $346.39M(+64.4%) | $99.06M(+1.5%) | $346.39M(+13.5%) |
| Sep 2013 | - | $97.61M(+34.7%) | $305.07M(+19.9%) |
| Jun 2013 | - | $72.46M(-6.2%) | $254.34M(+10.8%) |
| Mar 2013 | - | $77.26M(+33.8%) | $229.59M(+8.9%) |
| Dec 2012 | $210.75M(+79.7%) | $57.74M(+23.2%) | $210.75M(+11.3%) |
| Sep 2012 | - | $46.88M(-1.7%) | $189.37M(+8.0%) |
| Jun 2012 | - | $47.70M(-18.4%) | $175.40M(+15.2%) |
| Mar 2012 | - | $58.43M(+60.7%) | $152.28M(+29.9%) |
| Dec 2011 | $117.26M(+79.8%) | $36.35M(+10.4%) | $117.26M(+15.5%) |
| Sep 2011 | - | $32.92M(+33.9%) | $101.55M(+20.5%) |
| Jun 2011 | - | $24.59M(+5.0%) | $84.30M(+13.3%) |
| Mar 2011 | - | $23.41M(+13.4%) | $74.39M(+14.1%) |
| Dec 2010 | $65.20M(+23.2%) | $20.64M(+31.8%) | $65.20M(+5.9%) |
| Sep 2010 | - | $15.66M(+6.7%) | $61.59M(+4.8%) |
| Jun 2010 | - | $14.68M(+3.2%) | $58.77M(+5.5%) |
| Mar 2010 | - | $14.22M(-16.5%) | $55.73M(+5.3%) |
| Dec 2009 | $52.92M(+8.3%) | $17.03M(+32.6%) | $52.92M(+8.2%) |
| Sep 2009 | - | $12.84M(+10.4%) | $48.91M(+3.1%) |
| Jun 2009 | - | $11.63M(+1.9%) | $47.44M(-3.8%) |
| Mar 2009 | - | $11.42M(-12.3%) | $49.31M(+0.8%) |
| Dec 2008 | $48.88M | $13.02M(+14.6%) | $48.91M(+3.3%) |
| Sep 2008 | - | $11.37M(-15.8%) | $47.33M(+4.6%) |
| Jun 2008 | - | $13.49M(+22.4%) | $45.25M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $11.02M(-3.6%) | $40.69M(+7.5%) |
| Dec 2007 | $37.87M(+46.2%) | $11.44M(+23.1%) | $37.87M(+11.2%) |
| Sep 2007 | - | $9.29M(+4.0%) | $34.05M(+10.6%) |
| Jun 2007 | - | $8.94M(+8.9%) | $30.78M(+9.4%) |
| Mar 2007 | - | $8.20M(+7.5%) | $28.15M(+8.7%) |
| Dec 2006 | $25.89M(+1.6%) | $7.63M(+26.7%) | $25.89M(+2.9%) |
| Sep 2006 | - | $6.02M(-4.4%) | $25.16M(-0.8%) |
| Jun 2006 | - | $6.30M(+5.9%) | $25.36M(+0.3%) |
| Mar 2006 | - | $5.95M(-13.8%) | $25.28M(-0.8%) |
| Dec 2005 | $25.48M(+49.3%) | $6.89M(+10.9%) | $25.48M(+8.7%) |
| Sep 2005 | - | $6.22M(+0.0%) | $23.43M(+9.5%) |
| Jun 2005 | - | $6.22M(+1.1%) | $21.40M(+10.2%) |
| Mar 2005 | - | $6.15M(+26.6%) | $19.42M(+13.8%) |
| Dec 2004 | $17.06M(+15.4%) | $4.85M(+16.0%) | $17.06M(+3.7%) |
| Sep 2004 | - | $4.18M(-1.2%) | $16.45M(+3.7%) |
| Jun 2004 | - | $4.24M(+11.7%) | $15.86M(+4.9%) |
| Mar 2004 | - | $3.79M(-10.5%) | $15.12M(+2.2%) |
| Dec 2003 | $14.79M(+18.0%) | $4.24M(+17.7%) | $14.79M(+6.3%) |
| Sep 2003 | - | $3.60M(+3.2%) | $13.91M(+6.0%) |
| Jun 2003 | - | $3.49M(+0.8%) | $13.12M(+4.2%) |
| Mar 2003 | - | $3.46M(+2.8%) | $12.59M(+0.5%) |
| Dec 2002 | $12.53M(+30.4%) | $3.37M(+19.7%) | $12.53M(+5.3%) |
| Sep 2002 | - | $2.81M(-4.9%) | $11.90M(+3.0%) |
| Jun 2002 | - | $2.96M(-13.1%) | $11.55M(+5.2%) |
| Mar 2002 | - | $3.40M(+24.5%) | $10.98M(+14.3%) |
| Dec 2001 | $9.61M(+15.6%) | $2.73M(+11.0%) | $9.61M(-2.9%) |
| Sep 2001 | - | $2.46M(+3.3%) | $9.89M(+7.5%) |
| Jun 2001 | - | $2.38M(+17.3%) | $9.20M(+7.5%) |
| Mar 2001 | - | $2.03M(-32.7%) | $8.56M(-10.4%) |
| Dec 2000 | $8.31M(+29.8%) | $3.02M(+70.7%) | $9.55M(+16.0%) |
| Sep 2000 | - | $1.77M(+1.6%) | $8.24M(+2.1%) |
| Jun 2000 | - | $1.74M(-42.5%) | $8.07M(+3.1%) |
| Mar 2000 | - | $3.03M(+78.0%) | $7.83M(+5.8%) |
| Dec 1999 | $6.40M(+10.3%) | $1.70M(+6.3%) | $7.40M(+4.2%) |
| Sep 1999 | - | $1.60M(+6.7%) | $7.10M(+4.4%) |
| Jun 1999 | - | $1.50M(-42.3%) | $6.80M(-2.9%) |
| Mar 1999 | - | $2.60M(+85.7%) | $7.00M(+20.7%) |
| Dec 1998 | $5.80M(0.0%) | $1.40M(+7.7%) | $5.80M(+3.6%) |
| Sep 1998 | - | $1.30M(-23.5%) | $5.60M(-1.8%) |
| Jun 1998 | - | $1.70M(+21.4%) | $5.70M(0.0%) |
| Mar 1998 | - | $1.40M(+16.7%) | $5.70M(-1.7%) |
| Dec 1997 | $5.80M(-1.7%) | $1.20M(-14.3%) | $5.80M(-3.3%) |
| Sep 1997 | - | $1.40M(-17.6%) | $6.00M(0.0%) |
| Jun 1997 | - | $1.70M(+13.3%) | $6.00M(-52.8%) |
| Mar 1997 | - | $1.50M(+7.1%) | $12.70M(0.0%) |
| Dec 1996 | $5.90M(+1.7%) | $1.40M(0.0%) | $12.70M(+1.6%) |
| Sep 1996 | - | $1.40M(-83.3%) | $12.50M(0.0%) |
| Jun 1996 | - | $8.40M(+460.0%) | $12.50M(+119.3%) |
| Mar 1996 | - | $1.50M(+25.0%) | $5.70M(-1.7%) |
| Dec 1995 | $5.80M(-31.8%) | $1.20M(-14.3%) | $5.80M(-18.3%) |
| Sep 1995 | - | $1.40M(-12.5%) | $7.10M(-7.8%) |
| Jun 1995 | - | $1.60M(0.0%) | $7.70M(-8.3%) |
| Mar 1995 | - | $1.60M(-36.0%) | $8.40M(-1.2%) |
| Dec 1994 | $8.50M(-81.6%) | $2.50M(+25.0%) | $8.50M(-82.2%) |
| Sep 1994 | - | $2.00M(-13.0%) | $47.70M(+0.8%) |
| Jun 1994 | - | $2.30M(+35.3%) | $47.30M(-14.6%) |
| Mar 1994 | - | $1.70M(-95.9%) | $55.40M(-13.8%) |
| Dec 1993 | $46.30M(+66.5%) | $41.70M(+2506.3%) | $64.30M(+111.5%) |
| Sep 1993 | - | $1.60M(-84.6%) | $30.40M(-16.3%) |
| Jun 1993 | - | $10.40M(-1.9%) | $36.30M(+13.1%) |
| Mar 1993 | - | $10.60M(+35.9%) | $32.10M(+15.5%) |
| Dec 1992 | $27.80M(+742.4%) | $7.80M(+4.0%) | $27.80M(+36.3%) |
| Sep 1992 | - | $7.50M(+21.0%) | $20.40M(+38.8%) |
| Jun 1992 | - | $6.20M(-1.6%) | $14.70M(+61.5%) |
| Mar 1992 | - | $6.30M(+1475.0%) | $9.10M(+225.0%) |
| Dec 1991 | $3.30M(+94.1%) | $400.00K(-77.8%) | $2.80M(+16.7%) |
| Sep 1991 | - | $1.80M(+200.0%) | $2.40M(+300.0%) |
| Jun 1991 | - | $600.00K | $600.00K |
| Dec 1990 | $1.70M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual SGA year-on-year change?
- What is Regeneron Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly SGA year-on-year change?
- What is Regeneron Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM SGA year-on-year change?
What is Regeneron Pharmaceuticals annual SGA?
The current annual SGA of REGN is $2.95B
What is the all time high annual SGA for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual SGA is $2.95B
What is Regeneron Pharmaceuticals annual SGA year-on-year change?
Over the past year, REGN annual SGA has changed by +$323.10M (+12.28%)
What is Regeneron Pharmaceuticals quarterly SGA?
The current quarterly SGA of REGN is $633.00M
What is the all time high quarterly SGA for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly SGA is $792.20M
What is Regeneron Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, REGN quarterly SGA has changed by -$56.00M (-8.13%)
What is Regeneron Pharmaceuticals TTM SGA?
The current TTM SGA of REGN is $124.23B
What is the all time high TTM SGA for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM SGA is $124.23B
What is Regeneron Pharmaceuticals TTM SGA year-on-year change?
Over the past year, REGN TTM SGA has changed by +$121.51B (+4468.52%)